Skip to main content

Chilmark Research

Xealth, the leader in enabling digital health at scale, today announced that CEO Mike McSherry will join industry leaders for a Chilmark Research roundtable discussion on Tuesday, June 22, titled “Virtual Care and Beyond: The Advent of Omnichannel Care.”

This session will discuss various approaches to integrating virtual care into the clinical workflow, emerging best practices, and considerations for health organizations planning their own implementation strategy.

Roundtable Details

Who Donald Rucker, former National Coordinator, Office of the National Coordinator
Mike McSherry, CEO, Xealth
Julia Millard, VP of Customer Success and Services, Bright.MD
Moderated by: Alex Lennox-Miller, Senior Analyst, Chilmark Research
When Tuesday, June 22
1:00 PM ET / 10:00 AM PT
Length 60 minutes
Register Click here to register

“This past year has given virtual care a solid foundation in which to help shape how care delivery looks moving forward,” said Mike McSherry, CEO and co-founder of Xealth. “It is not an either/or conversation. Organizations that are smart about how they incorporate digital tools to augment in-person care for improving the experience for both patients and clinicians will see the biggest benefit. This is a pivotal moment for health care.”

About Xealth

Xealth scales digital health programs, enabling clinicians to integrate, prescribe and monitor digital health tools for patients to drive engagement and utilization. Through the secure Xealth platform, clinicians can find and order the right digital health tools and programs for patients direct from the EHR workflow, send these digital health orders to the patient’s email or patient portal, and then monitor activity. Xealth spun out of Providence St. Joseph Health (PSJH) in 2017, and investors include Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, Cerner, McKesson Ventures, Novartis, Philips, and ResMed as well as Providence Ventures, UPMC and the Froedtert and Medical College of Wisconsin Health Network.

For more information, visit or follow us on LinkedIn or Twitter.

Close Menu